oral semaglutide nejm 🔴Tirzepatide as Compared with for the Treatment of Obesity⤵️ @ 🔹Among participants with obesity but without diabetes, treatment with tirzepatide was superior to treatment with semaglutide with respect to reduction in soul trial oral semaglutide cardiovascular

Semaglutide is a glucagon-like peptide-1 ( GLP-1 ) receptor agonist

It may also be considered for patients who have not reached their goals with other options, depending on health history and provider judgment

Your focus should be on building a comprehensive treatment plan that includes not just the medication but also nutritional support, physical activity modifications, and monitoring for the more significant side effects that can accompany larger doses

For some patients, this combination may lead to more significant weight loss results than either medication alone

While constipation is common with GLP-1 agonists, it should respond to standard remedies